Great Britain
|
Nexgard Spectra 150 mg / 30 mg Chewable Tablets for Dogs >30–60 kg
|
Boehringer Ingelheim Vetmedica Gmbh
|
04491/5031
|
-
Afoxolaner
-
Milbemycin Oxime (A3 and A4)
|
|
POM-V
|
|
Great Britain
|
RenuTend Suspension for Injection for Horses
|
Boehringer Ingelheim Vetmedica GmbH
|
04491/5064
|
-
Tenogenic primed equine allogeneic peripheral blood-derived mesenchymal stem cells (tpMSCs)
|
|
POM-V
|
|
Northern Ireland
|
Arti-Cell Forte Suspension for Injection for Horses
|
Boehringer Ingelheim Vetmedica GmbH
|
EU/2/18/228/001
|
-
Chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells
|
|
POM-V
|
|
Northern Ireland
|
Eurican Herpes 205 Powder and Solvent for Emulsion for Injection
|
Boehringer Ingelheim Vetmedica Gmbh
|
EU/2/01/029/001-003
|
|
|
POM-V
|
|
Northern Ireland
|
Frontpro 11 mg Chewable Tablets for Dogs 2–4 kg
|
Boehringer Ingelheim Vetmedica Gmbh
|
EU/2/19/240/001-004
|
|
|
NFA-VPS
|
|
Northern Ireland
|
Frontpro 136 mg Chewable Tablets for Dogs >25–50 kg
|
Boehringer Ingelheim Vetmedica Gmbh
|
EU/2/19/240/013-016
|
|
|
NFA-VPS
|
|
Northern Ireland
|
Frontpro 28 mg Chewable Tablets for Dogs >4–10 kg
|
Boehringer Ingelheim Vetmedica Gmbh
|
EU/2/19/240/005-008
|
|
|
NFA-VPS
|
|
Northern Ireland
|
Frontpro 68 mg Chewable Tablets for Dogs >10–25 kg
|
Boehringer Ingelheim Vetmedica Gmbh
|
EU/2/19/240/009-012
|
|
|
NFA-VPS
|
|
Northern Ireland
|
NexGard 11 mg Chewable Tablets for Dogs 2-4 kg
|
Boehringer Ingelheim Vetmedica Gmbh
|
EU/2/13/159/001-003,013,017
|
|
|
POM-V
|
|
Northern Ireland
|
NexGard 136 mg Chewable Tablets for Dogs >25-50 kg
|
Boehringer Ingelheim Vetmedica Gmbh
|
EU/2/13/159/010-012,016,020
|
|
|
POM-V
|
|
Northern Ireland
|
NexGard 28 mg Chewable Tablets for Dogs >4-10 kg
|
Boehringer Ingelheim Vetmedica Gmbh
|
EU/2/13/159/004-006,014,018
|
|
|
POM-V
|
|
Northern Ireland
|
NexGard 68 mg Chewable Tablets for Dogs >10-25 kg
|
Boehringer Ingelheim Vetmedica Gmbh
|
EU/2/13/159/007-009,015,019
|
|
|
POM-V
|
|
Northern Ireland
|
Nexgard Spectra 150 mg / 30 mg Chewable Tablets for dogs >30–60 kg
|
Boehringer Ingelheim Vetmedica Gmbh
|
EU/2/14/177/013-015,020
|
-
Afoxolaner
-
Milbemycin Oxime (A3 and A4)
|
|
POM-V
|
|
Northern Ireland
|
Nexgard Spectra 19 mg / 4 mg Chewable Tablets for Dogs >3.5–7.5 kg
|
Boehringer Ingelheim Vetmedica Gmbh
|
EU/2/14/177/004-006,017
|
-
Afoxolaner
-
Milbemycin Oxime (A3 and A4)
|
|
POM-V
|
|
Northern Ireland
|
Nexgard Spectra 38 mg / 8 mg Chewable Tablets for Dogs >7.5–15 kg
|
Boehringer Ingelheim Vetmedica Gmbh
|
EU/2/14/177/007-009,018
|
-
Afoxolaner
-
Milbemycin Oxime (A3 and A4)
|
|
POM-V
|
|
Northern Ireland
|
Nexgard Spectra 75 mg / 15 mg Chewable Tablets for Dogs >15–30 kg
|
Boehringer Ingelheim Vetmedica Gmbh
|
EU/2/14/177/010-012,019
|
-
Afoxolaner
-
Milbemycin Oxime (A3 and A4)
|
|
POM-V
|
|
Northern Ireland
|
Nexgard Spectra 9 mg / 2 mg Chewable Tablets for Dogs 2–3.5 kg
|
Boehringer Ingelheim Vetmedica Gmbh
|
EU/2/14/177/001-003,016
|
-
Afoxolaner
-
Milbemycin Oxime (A3 and A4)
|
|
POM-V
|
|
Northern Ireland
|
PREVEXXION RN+HVT+IBD Concentrate and Solvent for Suspension for Injection
|
Boehringer Ingelheim Vetmedica Gmbh
|
EU/2/20/255/001-003
|
-
Marek's disease virus
-
Turkey herpesvirus
|
|
POM-V
|
|
Northern Ireland
|
Purevax RCP
|
Boehringer Ingelheim Vetmedica Gmbh
|
EU/2/04/052/001-004
|
-
Feline calicivirus
-
Feline panleukopenia virus
-
Feline viral rhinotracheitis virus
|
|
POM-V
|
|
Great Britain
|
Arti-Cell Forte Suspension for Injection for Horses
|
Boehringer Ingelheim Vetmedica GmbH
|
04491/5062
|
-
Chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells
|
|
POM-V
|
|